Outcomes Associated With Andexanet Use in Patients With Factor Xa Inhibitor-Associated Intracranial Hemorrhage: A One-Year Single-Center Analysis

被引：0
|
作者：
Concha, M. [1 ]
Shomo, E. [1 ]
Busey, K., V [1 ]
Case, D. [1 ]
Brockhurst, A. [1 ]
Giovino, A. [1 ]
机构：
[1] Sarasota Mem Hosp, Sarasota, FL USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2019年 / 74卷 / 04期
关键词：
D O I：
10.1016/j.annemergmed.2019.08.369
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
201
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] TIME TO 4F-PCC AND BLOOD PRESSURE CONTROL IN FACTOR XA INHIBITOR-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Vilar, Jason
    Priano, James
    Rzasa, Kaitlin
    CRITICAL CARE MEDICINE, 2020, 48
  • [42] Effectiveness of high- versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated intracranial hemorrhage
    Baker, W.
    Cassano, C.
    Karadenes, A.
    Coleman, C. I.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [43] mTOR inhibitor-associated noninfectious pneumonitis in patients with metastatic renal cell cancer: A single-center experience.
    Cauley, Diana H.
    Atkinson, Bradley J.
    Ng, Chaan S.
    Millikan, Randall E.
    Xiao, Lianchun
    Corn, Paul Gettys
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Meta-Analysis and Meta-Regression to Assess Four-Factor Prothrombin Complex Concentrate's Ability to Achieve Hemostatic Effectiveness in Patients with Oral Factor Xa Inhibitor-Associated Intracranial Hemorrhage
    Caroti, Kimberly Snow
    Lemere, Peter
    Coleman, Craig, I
    BLOOD, 2022, 140 : 8520 - 8521
  • [45] Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis
    Smith, Christiana D.
    Fought, Angela B.
    Sung, Joyce
    McKinney, Jennifer
    Metz, Torri
    Fetters, Kirk
    Lazarus, Sarah
    Capraro, Shannon
    Barr, Emily
    Glenny, Carrie
    Buehler, Jenna
    Weinberg, Adriana
    PLOS ONE, 2023, 18 (06):
  • [46] IMPACT OF TIMING OF 4F-PCC ADMINISTRATION ON OUTCOMES IN ORAL FACTOR XA INHIBITOR-ASSOCIATED ICH
    Jaszcz, Sarah
    Wein, Rachel
    Mangan, Kyle
    Mohamed, Wazim
    Parker, Dennis
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [47] ANTICOAGULANT-ASSOCIATED INTRACRANIAL HEMORRHAGE: PATIENT CHARACTERISTICS AND OUTCOMES FROM A SINGLE-CENTER OBSERVATIONAL STUDY IN A NEUROLOGICAL HOSPITAL
    Garcia Rivera, J.
    Cano-Nigenda, V.
    Mercado Pompa, A.
    Moreno Arias, J.
    Enriquez Peregrino, K.
    Reyes Cortes, I.
    Juarez Comboni, S. C.
    Benitez Renteria, S.
    Camacho Gamez, I.
    Pereda Castillo, A.
    Vasquez Zevallos, M.
    Valdovinos Rodriguez, O.
    Romero Vucovich, R.
    Gonzalez Sansores, E.
    Arauz, A.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 403 - 403
  • [48] Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience
    Fahed, Elie
    Ghauche, Jessica
    Rahme, Ralph
    Okais, Nabil
    Samaha, Elie
    Nohra, Georges
    Rizk, Tony
    Maarrawi, Joseph
    Menassa-Moussa, Lina
    Moussa, Ronald
    WORLD NEUROSURGERY, 2016, 95 : 143 - 147
  • [49] Characterization and clinical outcomes of JAK inhibitor-associated acne (JAK-acne) in patients with alopecia areata treated with tofacitinib: a single-center retrospective study
    Huang, Jundong
    Ji, Ruxin
    Li, Ji
    Guo, Yong
    Shi, Wei
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (11) : e350 - e352
  • [50] Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor-associated major bleeding
    Kimpton, Miriam
    Siegal, Deborah M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 204 - 208
12345